Department of Ophthalmology, Rigshospitalet-Glostrup Valdemar Hansens Vej 13, 2600 Glostrup, Denmark
Who is this study for? Patients with open angle glaucoma or ocular hypertension
What treatments are being studied? Xalatan
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
a randomized, investigator-blind, interventinal study will compare the effect of benzalkonium-chloride (BAK) preserved and preservative-free (PF) eye drops on conjunctival goblet cells.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \>18years
• Danish speaking
• Open angle glaucoma or ocular hypertension
• Average intraocular pressure equal to or above 22 mmHg
Locations
Other Locations
Denmark
Department of drug design and pharmacology, University of Copenhagen
RECRUITING
Copenhagen
Department of ophthalmology, rigshospitalet.glostrup
NOT_YET_RECRUITING
Glostrup Municipality
Contact Information
Primary
Anne Nagstrup, MD
anne.hedengran.nagstrup@regionh.dk
+4522334504
Backup
Miriam Kolko, MD, PhD
miriamk@sund.ku.dk
Time Frame
Start Date: 2021-09-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 28
Treatments
Active_comparator: BAK-preserved
Xalatan eye drop
Active_comparator: Preservative-free
Monoprost eye drop
Related Therapeutic Areas
Sponsors
Leads: Rigshospitalet, Denmark
Collaborators: Laboratoires Thea